Beyond Paxlovid: Scientists Unveil Game-Changing Antiviral That Could Combat COVID, Ebola, and More
The Tuschl lab has pioneered a novel class of antivirals targeting viral methyltransferases, enzymes essential to RNA viruses like SARS-CoV-2, Ebola, and dengue, paving the way for more effective therapies. This innovative approach offers a highly …